While reporting weak earnings and higher revenues in its third quarter, drug maker Eli Lilly And Co. (LLY) on Tuesday trimmed its fiscal 2021 earnings view on a reported basis, while raised adjusted earnings and revenue forecast above market estimates.
In pre-market activity on the NYSE, Lilly shares were gaining around 2.02 percent to trade at $250.
For the year, the company now projects adjusted earnings of $7.95 to $8.05, higher than previous view of $7.80 to $8.00.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.